Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2024-03-06 Regulatory Filings
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - NVU 4 pages 15.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Nanoveu Limited. It provides specific information about securities that have ceased, including quantities, reasons for cessation, and updated issued capital figures. The document is a formal announcement to the ASX about changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement of a change in securities status. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-03-06 English
Notification of cessation of securities - NVU 4 pages 15.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Nanoveu Limited. It provides specific information about securities that have ceased, including the number, reason for cessation, and updated issued capital figures. The document is a formal announcement to the ASX about changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification of a capital change event related to securities. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4273 characters, which is consistent with a detailed announcement rather than a full report.
2024-03-06 English
Notification of cessation of securities - NVU 4 pages 14.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Nanoveu Limited, including the number of securities ceased, reasons for cessation, and updated issued capital figures. It is a regulatory announcement related to changes in the company's issued capital, specifically the cessation (expiry) of options. The document is relatively short (4165 characters) and is a formal notification to the ASX about securities ceasing to exist. This fits the category of Share Issue/Capital Change announcements, as it relates to changes in the company's capital structure due to expiry of options. Therefore, the appropriate classification is 'SHA' (Share Issue/Capital Change).
2024-03-06 English
Change of Director's Interest Notice 3 pages 172.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including shares, performance rights, and options, with specific dates and quantities. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, management discussion, or other report types. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is not an announcement or a brief notice but a formal disclosure of director's interest changes.
2024-03-06 English
Change of Director's Interest Notice 3 pages 169.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a company director, including shares, performance rights, and options, with specific dates and quantities. The content focuses on the director's personal share transactions and interests, including disposals and expiries of securities. The document length is 3756 characters, which is relatively short but contains detailed information about director share dealings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2024-03-06 English
Appendix 3G 18 pages 409.2KB
Regulatory Filings Classification · 100% confidence The document is an Appendix 3G form filed with the ASX, which is a notification of the issue, conversion, or payment up of unquoted equity securities. It includes detailed information about securities issued, dates, and amendments to previous announcements. The content is regulatory in nature, focused on notifying the market and ASX about securities transactions rather than presenting financial results or management commentary. It is not an annual report, earnings release, or management discussion. It is a specific regulatory filing related to securities issuance and amendments. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-03-06 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.